Pfizer has called on the biopharmaceutical industry to join the company in committing to unprecedented collaboration to combat COVID-19. “In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic,” Dr. Albert Bourla, the company’s Chairman and CEO, said in a statement. “Many companies, including Pfizer, are working…

Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub – Is Taiwan Ready for the Top Spot?” That provocative topic was the theme of a half-day conference – held April 25 at the Chang Yung-Fa Foundation’s International Convention Center – that featured a number of prominent expert speakers and panelists from both Taiwan and internationally. The…